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Phosphorylation of CypD at Serine 191
regulates the mPTP

INTRODUCTION
Background: Mitochondrial calcium overload and oxidative stress during ischemia
reperfusion (I/R) injury remains a major obstacle during percutaneous coronary
intervention after acute myocardial infarction. It often leads to an increased
susceptibility for mitochondria permeability transition pore (mPTP) opening leading to
cell death. Mitochondrial calcium overload and ROS have been identified as key
triggers to open the mPTP for over 30 years, yet the exact mechanism has remained
elusive. Additionally, glycogen synthase kinase 3β; (GSK-3β;) is proposed as one of the
key molecules that regulate mitochondrial dysfunction and injury during I/R. Indeed
inhibition of GSK-3β has been shown to be required for ischemic pre- and postconditioning. Interestingly inhibition of GSK-3β is detrimental during the ischemic
phase but beneficial only during the reperfusion stage of I/R injury.
Specific Aims:
1. Identify the GSK-3β mediated phosphorylation site(s) on CypD
2: Identify the key mechanism of site-specific phosphorylation of CypD on mPTP
regulation in the context of Ischemia Reperfusion Injury
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CypD Requires OSCP to modulate mPTP

HYPOTHESIS
Hypothesis: : Upon high mitochondrial Ca2+ and ROS, Calpain 1 is activated and
truncates GSK-3β. Truncated GSK-3β can now bind to and phosphorylate mCypD
inducing it to translocate to and bind the mPTP inducing sustained opening. If we
can selectively inhibit the formation of truncated GSK-3β we believe we can
prevent the pathological effects of GSK-3β previously attributed to the total pool
of GSK-3β, while keeping the physiological pool necessary for proper cell function.
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Phosphorylation at S191 Mediates the CypDOSCP Interaction
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Figure 5. CypD Regulation of the mPTP requires OSCP Typical curves of calcium retention capacity
(CRC) in HEK CypD-OSCP-KO cells rescued with different CypD mutants with or without simultaneous
OSCP rescue.
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Figure S1. Central hypothesis. (A):Table of the specific-GSK3β kinase post-translational
phosphorylation site of CypD from the amino acid sequence Human PPIF (Uniprot #P30405).
NetPhos 3.1 score of potential serine phosphorylation sites of CypD, and HTP (High Throughput
papers) score from PhosphoSitePlus : number of records in which this modification site was
assigned using only proteomic discovery mass spectrometry. Non applicable (na), phosphorylation
(p) (B): Elevated Ca2+ and ROS activates Calpain1 and Pyk-2. Calpain1 truncates the N and/or C
terminus of GSK-3β, which is phosphorylated by Pyk-2 increasing GSK-3β activity. The truncated
version of GSK is now able to bind to and phosphorylate mCypD causing it to translocate to the
ATP Synthase/mPTP complex causing sustained mPTP opening, cellular distress, and/or death. (C):
Regulatory sites of GSK-3β (D): Calpain1 mediated cleavage sites and resulting molecular weight of
GSK-3β. Yellow indicates aa. that are cleaved off Orange indicates amino acids cleaved off by the
Mitochondria Protein Peptidase.

MATERIALS AND METHODS
• Cells/Transfection: HEK 293T with xfect (Clontech) with Hygromycin
selection
• Antibodies: OSCP (Santa Cruz Biotechnology) PPIF/mCypD (Abcam),GAPDH
(Cell Signaling Technologies) Phospho-Serine (Millipore) FLAG (Genscript)
• Live cell observation: Laser scanning confocal microscope with Fluoview
software (Olympus).
• Animals: C57BL/6 Mice
• Data analysis: Fluorescence quantification was performed using Image J
software. Western Blot quantification performed by LiCor Image Studio Lite.
Statistical analysis performed on SPSS: T-Test or ANOVA followed by Tukeys
Post Hoc Test. Significance was set at P≤.05.
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Figure 3. Phosphorylation event of CypD at serine 191 modulates the binding of CypD to the mPTP.
(A) Representative images of HEK cells transfected with OSCP-Clover with WT or CypD mutants
Scarlet downstream of an IRES site. Cells were excited with a 458nm laser and emission at 505-540
nm and 575-620 nm with a 560 nm. Right panel: Quantification of FRET efficiency in WT,
phosphoresistant (S191A) and phosphomimetic (S191E) CypD mutants. (mean ± SD; n=3) (*p<0.05
vs. respective group). (B) Representative immunoblots and quantification of FLAG (CypD) and OSCP
following OSCP immunoprecipitation in HEK CypD mutant cell lines (fold vs. WT mean ± SD; n=3)
(*p<0.05 vs. respective group). (C) Proximity ligation assay between OSCP and CypD in HEK CypD-KO
cells rescued WT, S191A and S191E CypD mutants. Left panel: representative confocal microscopy
images of in situ OSCP-CypD interactions depicted as red dots. Nuclei appear in blue. Right panel:
quantification of the interactions per cell presented as a fold of WT (n=5 different experimental days
with 4 fields of 20-50 HEK cells per well) (*p<0.05 vs. respective group).
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Figure 2. Phosphorylation of CypD at Serine 191 regulates the mPTP (A-C):Typical curves of calcium
retention capacity (CRC) in HEK CypD-KO cells rescued with different CypD mutants. (D):
Quantification of CRC in different CypD mutants normalized to the protein content and maximum
protection afforded by 1 µM CsA. (mean ± SD, n=3) (*p<0.05 vs. KO, †p<0.05 vs. WT, and ‡p<0.05 vs.
S191A). CypD can be phosphorylated at multiple serine residues, but only the CypD phosphorylation
at S191 seems to impact the ability of CypD to regulate the mPTP opening.
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Figure 6. Phosphorylation of CypD at S191 regulates Myocardial infarction (A) Infarct size (AN)
expressed as a % of the area at risk (AR) in WT, S191A and S191E rescue in CypD-KO mice (mean ± SD,
*p<0.05 vs. respective group). (B) Scatterplot of AN over the AR of CypD KO hearts infected with 5x108
PFU WT, S191A, or S191E CypD adenovirus. (C) Representative infarcts. (D) Western blot of LV tissue
demonstrating levels of CypD rescue.(E) Summary of deaths during surgery.
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Figure 1. CypD is Phosphorylated at Serine (A): Representative western blot of the mitochondrial
fraction of HEK cells overexpressing FLAG-tagged mutants of CypD probed for phospho-serine (PSer) and FLAG; quantified on the right (mean ± SD, n=4/group) (*p<0.05 vs. WT). (B)
Immunoprecipitation of HEK cells pulled down with either anti flag or anti P-Serine and probed for
CypD and P-Ser; quantified on the right. (*p<0.05 vs. WT)

Figure 4. Phosphorylation of CypD at serine 191 regulates mitochondrial function and cell death
(A) Cell death measured by flow cytometry after 18h starvation stress in WT, phosphoresistant
(S191A) and phosphomimetic (S191E) CypD cell lines. (mean of PI-positive cells ± SD, n=15 different
experimental days with 10 000 events/assay) (*p<0.05 vs. respective group).
(B) ROS level
production of mutants measured by flow cytometry (mean of H2DCFDA relative fluorescence
intensity ± SD, n=3 different experimental days with 10 000 events/assay) (*p<0.05 vs. respective
group). (C) Oxidative phosphorylation measured on permeabilized CypD mutant cell lines after 18h
starvation stress. Mitochondrial respiration was measured with successive addition of complex I
substrate (Glutamate/Malate/Pyruvate), rotenone plus complex II substrate (Succinate) and TTFA
plus complex IV substrate (TMPD/Asc) then azide. Where OXPHOS tended to be improved in
phosphoresistant CypD group, the OXPHOS was drastically altered in phosphomimetic CypD mutant.
(mean of relative respiration rate ± SD, n=5 different experimental days with 1.8 million cells/assay)
(*p<0.05 vs. S191A).
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